when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Oncology · news · pharmadog

← back to Oncology

News · Oncology

1,496 stories

29dSTAT+: FDA expands Bayer lung cancer drug approvalstat

29dSTAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and morestat

29dEncoded raises $275M series F for Dravet syndrome gene therapybiospace

29dSTAT+: Cancer medicines remain in short supply across the U.S., survey findsstat

29dTyra shares slip as bladder cancer responses fall short of investor expectationsbiospace

29dA booming business on Wall Street would love more biotechs to quietly diebiopharma dive

29dOz says ‘AI-based avatars’ can help rural communities. Some leaders disagreestat

29dBridgeBio Oncology slides as it tightens the scope of its KRAS programendpoints

29dSTAT+: Roivant is one of the savviest dealmakers in biotech. It also has a secret weaponstat

29dSTAT+: What to expect from UniQure’s upcoming Huntington’s gene therapy readoutstat

29dTakeda’s long-serving R&D chief Andy Plump to retire in wake of pipeline successesfiercebiotech

29dTrump officials say AI will help save rural health care. Some leaders in the field don’t believe itstat

29dTyra disappoints investors with bladder cancer databiopharma dive

29dCEO O’Day tells Fierce how Gilead’s cancer, inflammation expansion has reached ‘critical mass’fiercebiotech

Sep 9, 26Kura spins diabetes work into a Lilly-backed biotech startupbiopharma dive

Sep 9, 26Webinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and Marketsbiospace

Sep 9, 26STAT+: Orexin discoverers awarded prestigious Lasker awardstat

Sep 9, 26STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and morestat

Sep 9, 26Novo’s canned heart disease trials, Novartis’ clinical fails, first approval for Alexander diseasebiospace

Sep 9, 26BMS clinches pivotal win for myeloma CAR T in ‘key derisking event’biospace

Sep 9, 26Telemedicine company offers GLP-1s for addictionstat

Sep 9, 26Solstice rises with $225M to develop next-gen CTLA-4 drug from Chinabiospace

Sep 9, 26Cancer biotech TwoStep gets $62.5M to take twist on ADCs into clinicendpoints

Sep 9, 26Kura Oncology spins out diabetes pipeline with $50M and Lilly's helpendpoints

Sep 9, 26Tyra claims Phase 2 win in bladder cancer, will advance drug to pivotal trialendpoints

Sep 9, 26A new immuno-oncology play raises $225M for a next-generation drugbiopharma dive

Sep 9, 26STAT+: Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that ideastat

Sep 9, 26Caspian launches with $50M, Lilly support to advance disease-modifying diabetes betbiospace

Sep 9, 26Tyra rolls toward pivotal bladder cancer study even as midphase data deflates stockfiercebiotech

Sep 9, 26Kura creates Lilly-backed spinout armed with $50M to advance next-gen diabetes therapyfiercebiotech

← prevpage 12 of 50next →